Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia 2023-12-24 17:53
Davos Communications Awards - BGI Genomics Inclusive Instagram Strategy Wins Gold Recognition 2023-12-22 08:19
TransThera Announces the Global Multicenter Phase 3 Clinical Trial Completed First Patient Dosing in the US Evaluating Tinengotinib in FGFRi Relapsed/Refractory Patients with Cholangiocarcinoma 2023-12-21 21:45
International Clinical Trial Results Released! Responding to the Virus Resurgence, Lianhua Qingwen Capsules Provide New Evidence 2023-12-21 18:06
CStone sells to Servier its exclusive rights to TIBSOVO® in Greater China and Singapore 2023-12-21 17:10
Everest Medicines' Partner Calliditas Therapeutics Announces Nefecon® the Only FDA-approved Treatment for IgA Nephropathy to Significantly Slow Kidney Function Decline 2023-12-21 10:30
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial 2023-12-21 08:26
CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors 2023-12-21 01:00
EpiVax Licenses ISPRI Toolkit to Eisai for Preclinical in silico Immunogenicity Screening 2023-12-20 23:45
Genevoyager Unveils Gene Therapy CDMO Facility in Milestone Move 2023-12-20 23:10
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum 2023-12-20 20:00
InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs 2023-12-20 09:00
Lynk Pharmaceuticals Announced First Rheumatoid Arthritis Patient Dosed in Phase Ⅲ Clinical Study of LNK01001 2023-12-20 08:00
Standigm named as a Tech Innovator in Generative AI in Drug Discovery use case 2023-12-19 22:00
Burjeel Holdings Oncology Conference Marks 10 Years, Focusing on Equitable Solutions for Cancer Care 2023-12-19 20:20
New Drug Application of Mabwell's 8MW0511 for Injection Accepted by NMPA 2023-12-19 20:00
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches 2023-12-19 20:00
Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation 2023-12-19 08:00
Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer 2023-12-19 05:44
EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures 2023-12-18 23:30
1 60 61 62 63 64 413